Why Is MacroGenics Stock Sinking Tuesday?

MacroGenics Inc. (NASDAQ:MGNX) shares are down during Tuesday’s premarket session following the announcement of a partial clinical hold on its Phase 2 LINNET study. The stock’s decline comes as the company is working closely with the FDA to resolve safety concerns...